NO148848C - Analogifremgangsmaate ved fremstilling av nye antibiotisk aktive spiroimidazolidin-rifamyciner - Google Patents

Analogifremgangsmaate ved fremstilling av nye antibiotisk aktive spiroimidazolidin-rifamyciner

Info

Publication number
NO148848C
NO148848C NO76762026A NO762026A NO148848C NO 148848 C NO148848 C NO 148848C NO 76762026 A NO76762026 A NO 76762026A NO 762026 A NO762026 A NO 762026A NO 148848 C NO148848 C NO 148848C
Authority
NO
Norway
Prior art keywords
rifamycines
spiroimidazolidine
preparation
new antibiotic
antibiotic active
Prior art date
Application number
NO76762026A
Other languages
English (en)
Norwegian (no)
Other versions
NO148848B (no
NO762026L (pt
Inventor
Leonardo Marsili
Vittorio Rossetti
Carmine Pasqualucci
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NO762026L publication Critical patent/NO762026L/no
Publication of NO148848B publication Critical patent/NO148848B/no
Publication of NO148848C publication Critical patent/NO148848C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO76762026A 1975-06-13 1976-06-11 Analogifremgangsmaate ved fremstilling av nye antibiotisk aktive spiroimidazolidin-rifamyciner NO148848C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT755174A IT1056272B (it) 1975-06-13 1975-06-13 Prodotti derivati dalle amine aromatiche

Publications (3)

Publication Number Publication Date
NO762026L NO762026L (pt) 1976-12-14
NO148848B NO148848B (no) 1983-09-19
NO148848C true NO148848C (no) 1983-12-28

Family

ID=11118842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO76762026A NO148848C (no) 1975-06-13 1976-06-11 Analogifremgangsmaate ved fremstilling av nye antibiotisk aktive spiroimidazolidin-rifamyciner

Country Status (28)

Country Link
US (2) US4086225A (pt)
JP (1) JPS5236683A (pt)
AR (1) AR211127A1 (pt)
AU (1) AU497602B2 (pt)
BE (1) BE842883A (pt)
CA (1) CA1059123A (pt)
CH (1) CH625524A5 (pt)
CS (1) CS197271B1 (pt)
DK (1) DK145228C (pt)
ES (1) ES449187A1 (pt)
FI (1) FI60208C (pt)
FR (1) FR2314189A1 (pt)
GB (1) GB1542063A (pt)
HK (1) HK56083A (pt)
HU (1) HU171396B (pt)
IE (1) IE42998B1 (pt)
IL (1) IL49701A (pt)
IN (1) IN143526B (pt)
IT (1) IT1056272B (pt)
NL (1) NL177919C (pt)
NO (1) NO148848C (pt)
PH (1) PH16410A (pt)
PL (1) PL99493B1 (pt)
PT (1) PT65208B (pt)
SE (1) SE434057B (pt)
SU (1) SU680649A3 (pt)
YU (1) YU39768B (pt)
ZA (1) ZA763256B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1056272B (it) * 1975-06-13 1982-01-30 Archifar Ind Chim Trentino Prodotti derivati dalle amine aromatiche
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
BE886395A (fr) * 1980-02-13 1981-03-16 Erba Farmitalia Derives de rifamycine
IT1201963B (it) * 1983-03-24 1989-02-02 Prodotti Antibiotici Spa Derivati delle rifamicine e procedimento per la loro preparazione
US4631290A (en) * 1985-08-29 1986-12-23 American Home Products Corporation Method of treating hepatitis
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
DE69400631T2 (de) * 1993-05-05 1997-02-27 Palo Alto Medical Found Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
ES2218597T3 (es) * 1995-09-01 2004-11-16 Kaneka Corporation Uso de derivados de rifamicina para la fabricacion de un medicamento para el tratamiento de enfermedades causadas por infecciones de helicobacter pylori.
EP1453837A4 (en) * 2001-11-21 2007-11-07 Activbiotics Inc TARGETED THERAPEUTIC AGENTS AND USES THEREOF
AU2002364162A1 (en) * 2001-12-13 2003-06-30 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
ES2246155B1 (es) * 2004-07-19 2007-03-16 Universidad De Oviedo Nuevas espiropiperidilrifamicinas.
CN101282981B (zh) 2005-08-11 2012-09-26 塔甘塔治疗公司 膦酸化利福霉素及其在预防和治疗骨和关节感染中的用途
WO2008008480A2 (en) * 2006-07-12 2008-01-17 Cumbre Pharmaceuticals Inc. Nitroheteroaryl-containing rifamycin derivatives
CN100569778C (zh) * 2006-12-05 2009-12-16 四川明欣药业有限责任公司 一种利福布汀结晶工艺
WO2009064792A1 (en) * 2007-11-16 2009-05-22 Cumbre Pharmaceuticals Inc. Quinolone carboxylic acid-substituted rifamycin derivatives
WO2010019511A2 (en) 2008-08-13 2010-02-18 Targanta Therapeutics Corp. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
EP2890374B1 (en) 2012-08-30 2019-04-03 The Texas A&M University System Compositions and methods for drug-sensitization or inhibition of a cancer cell
PH12013000351A1 (en) 2013-11-22 2015-05-25 Joselle A Macrohon A versatile queuing management system and method
US20170202850A1 (en) 2014-07-21 2017-07-20 Hiroaki Serizawa Ophthalmic compositions of rifamycins and uses thereof
CN106279205B (zh) * 2015-05-12 2020-07-21 重庆华邦胜凯制药有限公司 制备利福霉素s衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130099C (pt) * 1963-10-11
DE2626296C2 (de) * 1975-06-13 1986-11-27 Farmitalia Carlo Erba S.p.A., Mailand/Milano Rifamycin-Verbindung und Verfahren zu seiner Herstellung
IT1056272B (it) * 1975-06-13 1982-01-30 Archifar Ind Chim Trentino Prodotti derivati dalle amine aromatiche

Also Published As

Publication number Publication date
YU140576A (en) 1982-06-30
US4086225A (en) 1978-04-25
FI60208B (fi) 1981-08-31
GB1542063A (en) 1979-03-14
DK258076A (da) 1976-12-14
ZA763256B (en) 1977-05-25
NL7606370A (nl) 1976-12-15
PH16410A (en) 1983-09-29
US4219478A (en) 1980-08-26
CA1059123A (en) 1979-07-24
FR2314189A1 (fr) 1977-01-07
IN143526B (pt) 1977-12-17
AU497602B2 (en) 1978-12-21
PL99493B1 (pl) 1978-07-31
JPS6121957B2 (pt) 1986-05-29
YU39768B (en) 1985-04-30
ES449187A1 (es) 1977-07-16
NL177919B (nl) 1985-07-16
FI761688A (pt) 1976-12-14
SE434057B (sv) 1984-07-02
FR2314189B1 (pt) 1980-10-31
SE7606640L (sv) 1976-12-14
AR211127A1 (es) 1977-10-31
IE42998B1 (en) 1980-12-03
DK145228C (da) 1983-02-28
IL49701A0 (en) 1976-08-31
NL177919C (nl) 1985-12-16
NO148848B (no) 1983-09-19
HK56083A (en) 1983-11-25
NO762026L (pt) 1976-12-14
DK145228B (da) 1982-10-11
IE42998L (en) 1976-12-13
FI60208C (fi) 1981-12-10
HU171396B (hu) 1978-01-28
AU1476976A (en) 1977-12-15
PT65208B (en) 1977-11-23
CS197271B1 (en) 1980-04-30
CH625524A5 (pt) 1981-09-30
JPS5236683A (en) 1977-03-22
BE842883A (fr) 1976-10-01
PT65208A (en) 1976-07-01
IT1056272B (it) 1982-01-30
SU680649A3 (ru) 1979-08-15
IL49701A (en) 1979-10-31

Similar Documents

Publication Publication Date Title
NO148848C (no) Analogifremgangsmaate ved fremstilling av nye antibiotisk aktive spiroimidazolidin-rifamyciner
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO145342C (no) Fremgangsmaate til fremstilling av nye fosfoglykolipid- og glykopeptidantibiotika
NO148290C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive polyenforbindelser
NO763732L (no) Fremgangsm}te for fremstilling av nye fenoletere
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO149174C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme tiazinderivater
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO152841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner.
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO146392C (no) Analogifremgangsmaate ved fremstilling av nye analgesisk aktive n-acetyl-para-aminofenyl-n`-acetyl-aminoalkansyreester-derivater
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO142865C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler
NO148642C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater
NO152654C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO145618C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive spiro-(1,3-dioxolan-4,3`-kinuclidin-forbindelser
NO150882C (no) Analogifremgangsmaate ved fremstilling av nye 1,4-benzoksazin-derivater
NO146571C (no) Analogifremgangsmaate ved fremstilling av anti-inflammatorisk aktive imidazoler
NO142625C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater
NO147150C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperidiner.
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater